BioSpace News Archive

Business

Xencor Reports Third Quarter 2017 Financial Results and Provides Clinical Pipeline Update

“Our third quarter results highlight the promise of our XmAb technology to create a broad pipeline of engineered antibodies with improved performance across a range of unmet needs,” said Bassil Dahiyat, Ph.D., president and chief executive officer of Xencor.

November 7, 2017

·

15 min read

Drug Development

Boehringer Ingelheim’s Efficacy and Safety Maintained in Patients Who Switched From Humira to Biosimilar Cyltezo

The 48-week data showed that Cyltezo is equivalent, with no clinically meaningful differences in efficacy, safety and immunogenicity to Humira in people with moderately-to-severely active RA, including in patients who switched from Humira to Cyltezo at week 24.

November 7, 2017

·

13 min read

Genetown

Optim Showcases ENTity Stroboscopy at Nation’s Largest Speech Pathology Conference

Optim announced today the addition of the company’s ENTity Stroboscopy product to its MobileFEES System.

November 7, 2017

·

3 min read

Lianluo Smart Announces Strategic Investment in Guardion Health Sciences

Lianluo Smart today announced that the Company and related party Digital Grid together invested a total of $5M in GHS, a San Diego-based leader company focused on ocular health technologies and products.

November 7, 2017

·

3 min read

Biotech Beach

Introducing Powerdot, Paving The Way in Smart Muscle Stimulation

Also known as EMS or e-stim, electrical muscle stimulation is an effective performance and recovery method that uses electrical impulses to cause a contraction in targeted muscles.

November 7, 2017

·

3 min read

Drug Development

Amgen Announces New Analyses of High-Risk Patient Subgroups From Repatha (evolocumab) Cardiovascular Outcomes Study at AHA Scientific Sessions 2017

Results will be presented at the AHA Scientific Sessions 2017 in Anaheim, Calif., Nov. 11-15.

November 7, 2017

·

21 min read

Business

Tech Company EmpiraMed Boosts Customer Domain Expertise by Hiring 2 Biopharmaceutical Industry Veterans

EmpiraMed today announced that two executives were hired who have deep biopharmaceutical industry experience.

November 7, 2017

·

2 min read

UCB Presents New Findings Advancing Patient Care for Chronic Inflammatory Diseases and Osteoporosis at 2017 ACR/ARHP Annual Meeting

Study findings suggest that opioids are vastly overprescribed as a treatment for pain associated with AS, often in lieu of more effective treatments such as anti-TNFs and NSAIDs.

November 7, 2017

·

22 min read

Policy

Statement from FDA Commissioner Scott Gottlieb, M.D., on implementation of agency’s streamlined development and review pathway for consumer tests that evaluate genetic health risks

In its consideration of GHR tests, the FDA seeks to strike a balance that provides for an efficient pathway to bring these tests to consumers, without sacrificing the assurances offered by FDA oversight.

November 7, 2017

·

5 min read

Pharm Country

One Drop Announces Regulatory Approval and Launch In Canada

One Drop today announced Health Canada approval for One Drop I Chrome, its Bluetooth-enabled blood glucose monitoring system that syncs directly with the One Drop Mobile app.

November 7, 2017

·

5 min read